Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Merck forges ahead with phase 3 trial of Humira biosimilar
BioPharma Dive
Fri, 03/4/16 - 02:00 pm
Tags:
Merck, Humira, biosimilar, MSB11022, AbbVie, psoriasis
Boehringer, AbbVie Said to Be in Cancer-Partnership Talks
Bloomberg
Mon, 02/29/16 - 10:58 am
Tags:
Boehringer, AbbVie, R&D, cancer
7 big pharma companies sign on to Parkinson's development group
BioPharma Dive
Wed, 02/24/16 - 11:49 am
Tags:
R&D, AbbVie, AstraZeneca, Biogen, Eli Lilly, Merck, Pfizer, UCB Pharma, Parkinson's Disease
Will Merck Encroach On Gilead's Harvoni Territory?
Yahoo/Benzinga
Tue, 02/23/16 - 05:44 pm
Tags:
Merck, Gilead, Harvoni, AbbVie, hepatitis C, Viekira Pak, Zepatier
New results from low-T trial point to early win for AbbVie's AndroGel
Fierce Pharma
Thu, 02/18/16 - 09:18 pm
Tags:
low testosterone, AbbVie, Androgel
Looking ahead at orphan drugs' future: More breakthroughs, exploding sales
BioPharma Dive
Wed, 02/17/16 - 09:49 pm
Tags:
orphan drugs, Sumitomo Dainippon, obeticholic acid, AbbVie, venetoclax, Actelion, Uptravi
Harvoni’s New Label Gives Gilead Edge Over AbbVie
Bidness, ETC
Wed, 02/17/16 - 10:42 am
Tags:
Harvoni, labeling, Gilead Sciences, AbbVie, Viekira Pak, hepatitis C
AbbVie and Gilead Sciences Lead 2015 Drug Sales with Humira & Harvoni
Bidness, ETC
Thu, 02/11/16 - 09:01 pm
Tags:
AbbVie, Gilead Sciences, Humira, Harvoni
AbbVie, Maker of World's No. 1 Drug, Bets Synthetic Biology Startup Can Raise the Bar
Forbes
Wed, 02/10/16 - 09:39 am
Tags:
AbbVie, Synlogic, R&D, inflammatory bowel disease
Is the Anti-TNF Lead of AbbVie, Amgen, JNJ Nearing an End?
Bidness, ETC
Mon, 02/8/16 - 11:01 am
Tags:
AbbVie, Amgen, JNJ, anti-TNF, Remicade
Seven $1 billion-plus drugs seen reaching market in 2016
Yahoo/Reuters
Thu, 02/4/16 - 09:29 am
Tags:
Intercept Pharmaceuticals, Gilead Sciences, Roche, AbbVie, Merck, obeticholic acid, emtricitabine
Forget Biosimilars: It's This Threat That Could Dent AbbVie's Top Line
Motley Fool
Sun, 01/31/16 - 01:37 pm
Tags:
AbbVie, biosimilars, Humira, baricitinib, rheumatoid arthritis, Incyte, Eli Lilly
AbbVie beats fourth-quarter profit expectations
Marketwatch
Fri, 01/29/16 - 10:25 am
Tags:
AbbVie, earnings
AbbVie Inc 4Q Earnings: What to Expect AbbVie Inc 4Q Earnings: What to Expect
Bidness, ETC
Thu, 01/28/16 - 09:00 pm
Tags:
AbbVie, earnings
Amgen's Humira biosim is one step closer to FDA approval. But how close is it to market?
Fierce Pharma
Tue, 01/26/16 - 09:01 pm
Tags:
Amgen, biosimilars, Humira, FDA, AbbVie
AbbVie’s Net Profit Margin Expected to Reach 29.8% in 4Q15
Yahoo/Market Realist
Tue, 01/26/16 - 09:15 am
Tags:
AbbVie, earnings
US Big Pharma: What To Watch For In Q4 Results
Yahoo/Benzinga
Mon, 01/25/16 - 10:20 pm
Tags:
earnings, Eli Lilly, JNJ, Bristol-Myers Squibb, AbbVie, Pfizer, Merck
Galapagos moves AbbVie-partnered drug into PhI as multipronged attack on CF takes shape
Fierce Biotech
Sat, 01/23/16 - 11:06 am
Tags:
Galapagos, AbbVie, GLPG2222, cystic fibrosis
AbbVie Expects Imbruvica Revenues to Reach $5 Billion in 2020
Yahoo/Market Realist
Wed, 01/20/16 - 09:27 pm
Tags:
AbbVie, Imbruvica, blood cancers
3 Scorned Biotechs Destined to Rebound
TheStreet.com
Wed, 01/20/16 - 10:25 am
Tags:
Merrimack Pharmaceuticals, Relypsa, Amgen, AbbVie, Dynavax

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.